Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis

Mario Angelico, Daniele Di Paolo, Massimo O. Trinito, Alessandra Petrolati, Antonio Araco, Settimio Zazza, Raffaella Lionetti, Carlo U. Casciani, Giuseppe Tisone

Research output: Contribution to journalArticle

Abstract

Long-term immunoprophylaxis with anti-HBs immunoglobulins (HBIg) is used to prevent hepatitis B (HBV) reinfection after liver transplantation for HBV-related cirrhosis. This approach is highly expensive. A recent report proposed posttransplant HBV vaccination with a reinforced schedule as an alternative strategy to allow HBIg discontinuation. We investigated the efficacy of a reinforced triple course of HBV vaccination in 17 patients transplanted for HBsAg - positive cirrhosis 2 to 7 years earlier. The first cycle consisted of 3 double intramuscular doses (40 μg) of recombinant vaccine at month 0, 1, and 2, respectively. This was followed, in nonresponders, by a second cycle of 6 intradermal 10 μg doses every 15 days. All nonresponders then received a third cycle identical to the first one. Vaccination started 4.5 months after HBIg discontinuation, and lamivudine (100 mg/day) was given throughout the study. All patients were seronegative for HBsAg and HBV-DNA (by PCR) and positive for anti-HBe, and 7 were positive for anti-HDV. After the first cycle one patient (#5, 53 years old, male) developed an anti-HBs titer of 154 IU/L, another (#12) reached a titer of 20 IU/L and the remainder had titers <10 IU/L. At month 7, patient #5 reached a titer of 687 IU/L. After the second cycle only one additional patient (#9) had a slight response (an anti-HBs titer of 37 IU/L). After the third cycle patient #9 rose to an anti-HBs titer of 280 IU/L, patient #12 dropped to 10 IU/L, and no other patient responded. In conclusion, a highly reinforced HBV vaccination program is effective only in a few patients who had liver transplants for HBV - related cirrhosis.

Original languageEnglish
Pages (from-to)176-181
Number of pages6
JournalHepatology
Volume35
Issue number1
DOIs
Publication statusPublished - 2002

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis'. Together they form a unique fingerprint.

  • Cite this

    Angelico, M., Di Paolo, D., Trinito, M. O., Petrolati, A., Araco, A., Zazza, S., Lionetti, R., Casciani, C. U., & Tisone, G. (2002). Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology, 35(1), 176-181. https://doi.org/10.1053/jhep.2002.30278